Clinical Trial Update: Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the response to and safety of an 8-day course of Phenoptin for phenylketonuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• Phenoptin

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonurias | Phase 2 | Status: COMPLETED